Giorgio Fiore

Giorgio Fiore

Auto-generated profile, based on publicly available information

Giorgio Fiore

Internal Medicine, Allergology and Clinical Immunology, Department of Emergency and Organ Transplatation, University of Bari, Bari, Italy

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2013 in Endocrine, Metabolic & Immune Disorders - Drug Targets
Verified
Journal Article
Closed access
IMIovino Michele
Iovino Michele
EGEdoardo Guastamacchia
Edoardo Guastamacchia
VGVito Giagulli
Vito Giagulli
GFGiorgio Fiore
Giorgio Fiore
BLBrunella Licchelli
Brunella Licchelli
Vincenzo TriggianiVincenzo Triggiani
Vincenzo Triggiani
In this review, we analyzed the role played by central and peripheral chemoreceptors (CHRs) in vasopressin (AVP) secretion control. Central neural pathways subserving osmotic and non-osmotic control of AVP secretion are strictly correlated to brain areas participating in chemoreception mechanisms. Among the different brain areas involved in central chemoreception, the most important site has been localized in the retrotrapezoid nucleus of the rostral ventrolateral medulla. These central CHRs are able to detect very small pH/CO2 fluctuations, participating in brain blood flow regulation, acid-base balance and blood pressure control. Decreases in arterial pH and increases in arterial pCO2 stimulate AVP release by the Supraoptic and Paraventricular Nuclei. Carotid CHRs transduce low arterial O2 tension into increased action potential activity, leading to bradycardia and coronary vasodilatation via vagal stimulation, and systemic vasoconstriction via catecholaminergic stimulation. Stimulation of carotid CHRs by hypoxia increases neurohypophyseal blood flow and AVP release, an effect inhibited by CHRs denervation. Two renal CHRs have been identified: Type R1 CHRs do not have a resting discharge but are activated by renal ischemia and hypotension; Type R2 CHRs have a resting discharge and respond to backflow of urine into the renal pelvis. Signals arising from renal CHRs modulate the activity of hypothalamic AVPergic neurons: activation of R1 and R2 CHRs, following increased intrapelvic pressure with solutions of mannitol, NaCl and KCl, produces a significant increase of AVP secretion and the same effect has been obtained by the intrarenal infusion of bradykinin, which excites afferent renal nerves, as well as by the electrical stimulation of these nerves.

1 March 2013 in Endocrine, Metabolic & Immune Disorders - Drug Targets
Verified
Journal Article
Closed access
PDF file
GFGiorgio Fiore
Giorgio Fiore
PSPatrizia Suppressa
Patrizia Suppressa
Vincenzo TriggianiVincenzo Triggiani
Vincenzo Triggiani
FRFrancesco Resta
Francesco Resta
CSCarlo Sabba
Carlo Sabba
Cardiac hypertrophy/remodeling manifests as a critical condition which may likely predispose to the risk of fatal heart failure and multiple organ dysfunction if not efficiently addressed, as a result of irreversible neuroendocrine, autonomic and immune system imbalances. Undeniably, the over-excitation of sympathetic and/or the breakdown of central parasympathetic tone play a significant role to be the basis of the persistent immune activation in chronic heart failure (CHF) which, to a certain extent, is primed by inflammatory reactions in the Central Nervous System. Moreover, till today, the clinical management of CHF seeks the identification of molecularly targeted drugs in comparison to those considered so far. This review focuses on the possible neuroimmune-mediated pathways involved in CHF and throws light on the current therapeutic strategies.

1 October 2013 in Endocrine, Metabolic & Immune Disorders - Drug Targets
Verified
Journal Article
Closed access
Vincenzo TriggianiVincenzo Triggiani
Vincenzo Triggiani
VGVito Giagulli
Vito Giagulli
BLBrunella Licchelli
Brunella Licchelli
FRFrancesco Resta
Francesco Resta
GFGiorgio Fiore
Giorgio Fiore
EGEdoardo Guastamacchia
Edoardo Guastamacchia
The clinical occurrence of ectopic thyroid gland is an infrequently encountered condition, resulting from a developmental abnormality during the migration of the thyroid anlage from the floor of the primitive foregut to its final position in the neck. It can be found along the way of thyroid descent, in the midline, or laterally in the neck or even in the mediastinum or under the diaphragm. This condition is often asymptomatic, whereas symptoms could be related to ectopic thyroid size, to its relationships with surrounding organs or to diseases affecting the ectopic thyroid in the same way they involve orthotopic glands. Sometimes, a growing mass can lead to the clinical suspicion of a tumor disease. On the other hand, thyroid ectopy must be distinguished from metastasis of thyroid cancer. Scintigraphy and ultrasonography are the main diagnostic means for evaluating ectopic thyroid tissue, whereas fine needle aspiration could be useful in the presence of a nodular ectopic gland or when the coexistence of an orthotopic thyroid can arise the suspicion of a metastasis from a thyroid cancer. Surgical removal is indicated in symptomatic cases, whereas radioiodine ablation is reserved to recurrent disease. In this paper we report an emblematic case of ectopic thyroid gland and a review of the literature dealing with this condition.

1 January 2001
Verified
Journal Article
Closed access
SAS Antonaci
S Antonaci
Giuseppina PiazzollaGiuseppina Piazzolla
Giuseppina Piazzolla
NNN Napoli
N Napoli
FVF S Vella
F S Vella
GFG Fiore
G Fiore
OSO Schiraldi
O Schiraldi

1 September 2006
Verified
Journal Article
Closed access
FVFrancesco Saverio Vella
Francesco Saverio Vella
Gianluigi  GiannelliGianluigi Giannelli
Gianluigi Giannelli
GFGiorgio Fiore
Giorgio Fiore
SASalvatore Antonaci
Salvatore Antonaci